Progenity, Inc.
4330 La Jolla Village Drive
Suite 200
San Diego
California
92122
United States
Website: https://www.progenity.com/
About Progenity, Inc.
Progenity is a biotechnology company with a market-leading presence in Women’s Health molecular testing and a pipeline of proprietary tests and therapeutic applications under development. Progenity has a portfolio of innovative technologies and tests for pre-eclampsia, genetic carrier testing, inheritable cancer genetics, liquid biopsy and noninvasive prenatal testing (NIPT), all designed to support clinicians in providing excellent patient care.
YEAR FOUNDED:
2002
JOBS:
7 articles with Progenity, Inc.
-
BioSpace Movers & Shakers, Oct. 25
10/25/2019
Pharma and life sciences companies strengthen their executive and leadership teams with this week's appointments. -
BioSpace Movers and Shakers, Aug. 9
8/9/2019
Biopharma companies strengthen their senior leadership teams and boards of directors. -
BioSpace Movers and Shakers, June 7
6/7/2019
Pharma and biotech companies strengthen their executive and leadership teams with new appointments. -
BioSpace Movers and Shakers: March 1
3/1/2019
Pharma and biotech companies make changes to leadership roles, with new hires at Agios, Notable, Rapamycin, Confo, AVEO and more. -
Progenity to Present at Three Key Investor Conferences
2/25/2019
Progenity, Inc., a privately held biotechnology company developing precision medicine solutions across genomic/epigenomic, proteomic, and microbiomic diagnostic and therapeutic platforms, announced that Harry Stylli, Ph.D., CEO, will be participating in several upcoming investor conferences.
-
Progenity Announces Expansion of Board of Directors
2/21/2019
Company Focused on Diagnostic and Therapeutic Precision Medicine Solutions in Prenatal and Perinatal Healthcare, Oncology, and Gastroenterology
-
Progenity snagged $125M in funding that will allow the company to accelerate development of its gastrointestinal platform.